Table 1.
Cystic Fibrosis | Obesity | Sickle Cell Disease | Inflammatory Bowel Disease | Epilepsy | Comparison Group | |
---|---|---|---|---|---|---|
(a) | (b) | (c) | (d) | (e) | (f) | |
n = 59 | n = 28 | n = 44 | n = 43 | n = 70 | n = 57 | |
M(SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |
or % | or % | or % | or % | or % | or % | |
Family-based Variables | ||||||
*Income:> 50K | 54%b, c, d | 25%a, d, f | 16%a, d, e, f | 93%a, b, c, e, f | 42%c, d | 51%b, c, d |
*Marital Status: single | 15%b, c, e, f | 62%a, d, e | 71%a, d, e, f | 5%b, c, e, f | 36%a, b, c, d | 38%a, c, d |
*# children in the home | 2.3 (0.9)d, e, f | 2.0 (0.8)c, d, e, f | 2.7 (1.6)b, d | 1.3 (1.0)a, b, c, e, f | 2.8 (1.1)a, b, d | 3.2 (1.9)a, b, d** |
Caregiver: mothers | 81% | 92% | 84% | 91% | 81% | 91% |
Child-based Variables | ||||||
*Child Age in years | 12.5 (4.2)b, c, d,e,f | 9.9 (2.0)a, d, f | 10.8 (1.5)a, d, e | 15.4 (1.4)a, b, c, e, f | 8.85 (2.0)a, c, d, f | 11.4 (3.2)a, b, d, e |
Range: 6–18 | Range: 5–12 | Range: 7–13 | Range: 13–18 | Range: 5–13 | Range: 6–17 | |
*Child Sex: female | 58%e | 68%d, e | 50% | 40%b, f | 37%a, b, f | 67%d, e |
Child Race | White: 98% | White: 32% | Black: 100% | White: 88% | White: 67% | White: 70% |
Black: 2% | Black: 54% | Black: 7% | Black: 20% | Black: 25% | ||
Other: 14% | Other: 5% | Other: 13% | Other: 5% | |||
Health/Disease Status or Severity Indicator | FEV1 % | BMI: 32.4 (5.7) | SS: 83% | PCDAI: 13.3 (10.1) | Partial: 56% | N/A |
predicted: 78.2 (25.3) | SC: 11% | LCAI: 3.1 (4.7) | Generalized: 31% | |||
zBMI: 2.5 (0.3) | SS+Thal: 6% | Unclassified: 13% |
Note.
Significant group differences were noted; superscript letters denote significant post-hoc differences.
Data was only available for n=26 of 57 children only.
FEV1: Forced expiratory volume in one second, BMI: Body Mass Index, zBMI: Standardized BMI, SS: Sickle Cell Anemia, SC: Sickle-Hemoglobin C Disease, SS+Thal: Sickle Beta-Plus Thalassemia, PCDAI: Pediatric Crohn's Disease Activity Index, LCAI: Lichtiger Colitis Activity Index.